Masitinib reduces asthma exacerbations in uncontrolled severe asthma
Masitinib significantly reduced asthma exacerbations in patients with severe asthma uncontrolled by oral corticosteroids compared with placebo treatment, according to new data. Masitinib (AB Science) is a first-in-class small tyrosine kinase inhibitor…